SIRNAOMICS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.26 HKD | -2.29% |
|
+1.97% | -79.72% |
| 05-10 | Sirnaomics Ltd. Appoints Edward Yongxiang Wang as Executive Director | CI |
| 04-17 | Sirnaomics Receives US FDA Guidance on Trials for Squamous Cell Carcinoma Treatment | MT |
Chart calendar Sirnaomics Ltd.
80e8fc1f05bdcbf6c04858.9XfKfbXBQMWovUGTuNxYQi7IOlo39QGNZIduHBi3hMs.r0P7MfmKN7zCkBDR0IwaFky4dSBnxUf0SbYmenf8zJ-7RK00w6M4j_n6AA~8061c571d55e299cd962a9796e7c9f98
Upcoming events on Sirnaomics Ltd.
Past events on Sirnaomics Ltd.
| 26/03/2024 | Q4 2023 Earnings Call |
| 26/03/2024 | Q4 2023 Earnings Release |
| 13/03/2024 19:40 | Oligonucleotide and mRNA Therapeutics Congress |
| 31/08/2023 14:30 | Q2 2023 Earnings Call |
| 30/08/2023 | Q2 2023 Earnings Release |
| 30/08/2023 17:15 | Oligonucleotides CMC & Analytical Development Summit |
| 30/08/2023 16:30 | Oligonucleotides CMC & Analytical Development Summit - Panel |
| 12/07/2023 12:35 | Drug Delivery Systems Conference |
| 19/06/2023 09:30 | STP705 isSCC Clinical Development Seminar |
| 15/06/2023 20:10 | RNA Therapeutics USA Conference |
| 13/06/2023 19:55 | Drug Discovery & Preclinical Summit |
| 18/04/2023 19:30 | American Association for Cancer Research Meeting |
| 29/03/2023 14:00 | Q4 2022 Earnings Call |
| 27/03/2023 | Q4 2022 Earnings Release |
| 20/03/2023 | RNAi Based Therapeutic Summit |
| 26/10/2022 21:00 | Drug Discovery Innovation Programme |
| 19/10/2022 19:10 | RNA Leaders USA Congress |
| 22/09/2022 17:30 | Oligonucleotide Therapeutics and Delivery Conference |
| 21/09/2022 16:20 | Oligonucleotide Therapeutics and Delivery Conference |
| 07/09/2022 | Jefferies Asia Forum |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 1,00 - | 0,00 0,00 - | 2,00 |
|
EBITDA Million USD | Released Forecast Spread | -55,2 -38,6 -43.02% | -87,9 -84,3 -4.32% | -71,4 -105 32.02% | -136 |
|
EBIT Million USD | Released Forecast Spread | -56,8 -40,0 -41.98% | -91,8 -87,6 -4.84% | -77,5 -103 24.72% | -134 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -216 -69,0 -212.95% | -97,4 -81,0 -20.22% | -85,0 -103 17.49% | -134 |
|
Net income Million USD | Released Forecast Spread | -213 -64,0 -232.92% | -88,3 -78,0 -13.2% | -78,7 -94,0 16.29% | -124 |
|
EPS USD | Released Forecast Spread | -2,42 -0,74 -227.71% | -1,16 -1,19 2.31% | -1,03 -1,06 2.83% | -1,41 |
| Announcement Date | 31/03/22 | 28/03/23 | 27/03/24 | - |
| Today 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 14/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 15/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 14:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 23/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 06:00 | ARGENX SE: Q2 2024 Earnings Release |
| 29/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Sirnaomics Ltd.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2257 Stock
- Calendar Sirnaomics Ltd.
